Adam Snook, PhD
Associate Professor
Contact
Featured Links
Adam Snook, PhD
Associate Professor
Education
PhD, Immunology and Microbial Pathogenesis, Thomas Jefferson University (2008)
BS, Pharmacology and Toxicology, University of the Sciences (2001)
Publications
- GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
- Biomarkers for Managing Neurodegenerative Diseases
- CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
- CD5 deletion enhances the antitumor activity of adoptive T cell therapies
- In vitro assays to evaluate CAR-T cell cytotoxicity
Expertise & Research Interests
My research has focused on the discovery and clinical development of novel cancer immunotherapeutics targeting the self/tumor antigen guanylyl cyclase C (GUCY2C; GCC). Please refer to my laboratory site for current research.